SARAH STRAHM: Open Payments
NPI 1831567825 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82 in 4 payments from 4 companies in 2025. Trend: 2023 $204 · 2024 $301 · 2025 $82
Food & beverage: $82
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Averitas Pharma Inc. | 1 | $15 |
Products named: INBRIJA, Ocrevus Zunovo, KESIMPTA, QUTENZA.
Industry payments across IN — which companies pay providers there.
